The Biotechnology Program in Mineral Metabolism is under the directorship of Dr. Charles Y.C. Pak. The focus of the program is to translate research done in the Center for Mineral Metabolism to patient care. This includes FDA submissions of New Drug Applications (NDA's) and Investigational Device Exemptions (IDE's) as well as coordinating many patient-oriented research projects.